BWXT (BWX Technologies, Inc.): Themes, ETFs, and Basket Ideas
Last updated June 2026
Short answer
What does BWX Technologies, Inc. do?
BWX Technologies is a US supplier of nuclear components and fuel, serving government and commercial customers. Its largest business is providing the nuclear reactors and reactor components that power the US Navy's submarines and aircraft carriers, a role in which it is effectively the sole-source manufacturer. BWXT also produces nuclear fuel and reactor parts, manages and operates national laboratory and government nuclear sites, handles nuclear materials, and increasingly pursues commercial opportunities in medical radioisotopes, advanced and small modular reactors, and nuclear components for the broader power industry. The company makes money largely through long-cycle government defense contracts that provide multi-year revenue visibility, supplemented by growing commercial and medical lines. Headquartered in Lynchburg, Virginia, BWXT operates specialized, highly regulated manufacturing facilities that are difficult to replicate, giving it a deep moat in naval nuclear propulsion.
Where is BWX Technologies, Inc. heading?
1. Naval nuclear propulsion backbone.
BWXT is the sole-source supplier of nuclear reactor components for US Navy submarines and carriers. Sustained US shipbuilding plans, including the Columbia-class submarine program and Virginia-class production, underpin a large, multi-year backlog. This franchise is mission-critical, deeply regulated, and protected by enormous barriers to entry, giving BWXT durable, visible defense revenue.
2. Commercial nuclear and SMR tailwinds.
Renewed interest in nuclear power, driven by clean-energy goals and surging data-center electricity demand, expands BWXT's commercial opportunity. The company supplies components and fuel for advanced reactors and small modular reactors and is positioned as a domestic manufacturer for next-generation nuclear, an area attracting government and private investment.
3. Medical radioisotopes.
BWXT is building a medical isotope business, including diagnostic and therapeutic radioisotopes such as technetium and actinium, used in imaging and targeted cancer treatment. This higher-margin, growing commercial segment diversifies the company beyond defense and taps a structurally expanding nuclear medicine market.
4. Government site management.
Through its technical services arm, BWXT manages and operates government nuclear and national laboratory facilities. These cost-reimbursable and fee-based contracts add steady cash flow and reinforce relationships across the US nuclear complex, including space nuclear propulsion work for NASA and the Department of Defense.
Risks worth tracking: BWXT is heavily dependent on US government defense spending; budget delays, continuing resolutions, or shifts in shipbuilding priorities could pressure revenue and backlog timing. Its naval franchise, while a moat, also concentrates customer risk in a single buyer. Commercial nuclear and SMR adoption may be slower than hoped, and the medical isotope and advanced-reactor businesses require capital and carry execution and regulatory risk. As a nuclear manufacturer, BWXT faces stringent regulatory oversight, safety liabilities, and long, complex project cycles. The stock often trades at a premium multiple that embeds optimistic nuclear-renaissance expectations, leaving it sensitive to disappointment.
Earnings and valuation (approximate, early 2026)
A simple financial snapshot. These are approximations and refresh quarterly; for current figures see BWX Technologies, Inc.'s investor relations page or your broker.
- Revenue (TTM): ~$2.7 billion
- Operating margin: ~14%
- Backlog: multi-billion, multi-year (government-anchored)
- Dividend yield: ~1%
- P/E (TTM): premium, often ~30x+ on nuclear-renaissance optimism
- Free cash flow: positive but capital-intensive due to facility expansion
- Segment mix: majority Government Operations, growing Commercial Operations
BWXT trades at a premium valuation for a defense-adjacted industrial, reflecting its sole-source naval moat plus optionality on the commercial nuclear and SMR theme. The defense backlog provides earnings visibility, while the rich multiple bakes in growth from medical isotopes and advanced reactors that has not yet fully materialized.
BWXT's competitors
Naval nuclear and defense
As sole-source for naval reactors, BWXT has no direct rival in that niche, but it operates within the broader defense-industrial base alongside shipbuilders like Huntington Ingalls and General Dynamics (its customers and partners) and competes for technical-services and government contracts with firms like Jacobs, Fluor, and Amentum.
Commercial and advanced nuclear
In commercial nuclear components and fuel for SMRs and advanced reactors, BWXT competes and partners with players such as Westinghouse, Centrus Energy, and various SMR developers (NuScale, X-energy, TerraPower) that it may also supply.
Medical isotopes
In nuclear medicine, BWXT competes with isotope producers and radiopharma suppliers including Lantheus, Curium, and other specialized isotope manufacturers.
Using BWXT in a Walnut basket
The most useful question to ask about a single stock is rarely “will it go up?”. It's “does this fit a thesis I actually believe in, and how do I size it alongside other stocks that fit the same thesis?” That's what Walnut is built for.
Open the AI assistant on Walnut and describe a thesis (for example: “the AI infrastructure buildout”, “dividend growth large-caps”, “global semiconductors”) where BWXT would naturally fit. The AI proposes 5 to 6 constituents with target weights, you review, and you can fund the basket through your broker once you're ready.
Build a basket around BWXT with Walnut
Use BWX Technologies, Inc. as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What is BWXT's ticker symbol?
+
BWXT, listed on the New York Stock Exchange. The company is BWX Technologies, headquartered in Lynchburg, Virginia. It trades during US market hours and is available at every major US brokerage.
What does BWX Technologies do?
+
BWXT supplies nuclear reactors, components, and fuel, most notably as the sole-source maker of nuclear propulsion systems for US Navy submarines and carriers. It also manages government nuclear sites, produces medical radioisotopes, and supplies components for commercial and advanced reactors.
Who are BWXT's main competitors?
+
In naval nuclear it is effectively sole-source. In technical services it competes with Jacobs, Fluor, and Amentum. In commercial and advanced nuclear, Westinghouse, Centrus, and SMR developers. In medical isotopes, Lantheus and Curium.
Why is BWXT considered a nuclear stock?
+
BWXT's core business is nuclear: it manufactures naval reactors, produces nuclear fuel and components, manages nuclear sites, and makes radioisotopes. It is one of the few pure-play public companies with deep manufacturing capability across both defense and commercial nuclear.
Is BWXT a defense stock?
+
Largely, yes. The majority of revenue comes from US government and defense work, especially naval nuclear propulsion. That gives it long-cycle, backlog-supported revenue similar to other defense contractors, while its commercial nuclear and medical segments add diversification.
Does BWXT benefit from data-center power demand?
+
Indirectly. Surging electricity demand from data centers and AI has renewed interest in nuclear power, including small modular reactors. BWXT supplies components and fuel for advanced reactors, positioning it as a potential beneficiary of a domestic nuclear buildout, though commercial adoption timelines remain uncertain.
Is BWXT a Industrials stock?
+
Yes. Under GICS classification, BWXT is in the Industrials sector, within aerospace and defense. It is held across industrial and defense ETFs and in broad market index funds.
Which ETFs hold BWXT?
+
Defense and aerospace ETFs such as ITA and PPA hold BWXT, as do some nuclear-energy thematic ETFs like NLR and URNM-adjacent funds. Broad small- and mid-cap index funds also hold it at smaller weights.
Is BWXT in the S&P 500?
+
BWXT is a mid-cap company and has been an S&P MidCap 400 constituent rather than a fixed S&P 500 member. Index membership can change over time, so its exact inclusion should be verified against current index listings.
What is BWXT's market cap?
+
Roughly in the mid-cap to large-cap range, often around $9-12 billion as of early 2026, reflecting strong investor enthusiasm for nuclear-themed names. The market cap has expanded with the nuclear-renaissance narrative.
Which thematic baskets typically include BWXT?
+
BWXT commonly appears in nuclear-energy, clean-energy, and defense baskets. It is also used in infrastructure or power-demand themes tied to data-center electricity growth and the broader nuclear revival.
Is BWXT a good stock to buy?
+
Descriptive, not a recommendation. The bull case is a sole-source naval nuclear moat with a large defense backlog, plus growth optionality in small modular reactors, advanced nuclear, and medical isotopes amid rising power demand. The bear case is heavy dependence on government budgets, a premium valuation that prices in an uncertain nuclear renaissance, and execution and regulatory risk in newer segments. Whether it fits any portfolio depends on individual goals and risk tolerance. Walnut is informational, not investment advice.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with BWX Technologies, Inc.'s investor relations page or your broker before making investment decisions.